Detalhe da pesquisa
1.
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
Oncologist
; 27(12): 1025-1033, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124727
2.
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Mol Carcinog
; 57(1): 106-113, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28892201